PCR analysis and specific immunohistochemistry revealing a high prevalence of non-Helicobacter pylori Helicobacters in Helicobacter pylori-negative gastric disease patients in Japan: High susceptibility to an Hp eradication regimen.


Journal

Helicobacter
ISSN: 1523-5378
Titre abrégé: Helicobacter
Pays: England
ID NLM: 9605411

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 31 12 2019
revised: 14 04 2020
accepted: 19 04 2020
pubmed: 14 8 2020
medline: 3 7 2021
entrez: 14 8 2020
Statut: ppublish

Résumé

The clinical significance of non-Helicobacter pylori Helicobacter (NHPH) is still unknown. There are many reports of NHPH-infected patients suffering from gastric diseases. Here, we investigated the polymerase chain reaction (PCR) positivity of NHPH infection in gastric disease patients who were negative for H. pylori (Hp) by the rapid urease test and by pathological observation. We collected the 296 endoscopically obtained gastric mucosal samples of Hp-negative gastric disease patients diagnosed based on a rapid urease test and pathology from 17 hospitals in Japan from September 2013 to June 2019, and we analyzed the existence of Hp and NHPH by PCR. The samples were also treated by indirect immunohistochemistry using an anti-Helicobacter suis VacA paralog antibody and were observed by confocal laser microscopy. Among the 236 non-Hp-eradicated cases, 49 cases (20.8%) were positive for NHPH. Among them, 20 cases were positive for Helicobacter suis, 7 cases were positive for Helicobacter heilmannii sensu stricto/ Helicobacter ailurogastricus (Hhss/Ha), and the other 22 cases could not be identified. The regional differences in the infection rates were significant. Forty percent of the nodular gastritis cases, 24% of the MALT lymphoma, 17% of the chronic gastritis cases, and 33% of the gastroduodenal ulcer cases were NHPH positive. Forty-five patients had been treated with one of the four types of combinations of a proton pump inhibitor and two antibiotics, and in all of these cases, the NHPH diagnosed by PCR was successfully eradicated. Immunohistochemistry using the Helicobacter suis-specific HsvA antibody coincided well with the PCR results. Among the 29 post-Hp eradication cases, three were NHPH positive, including one Hhss/Ha-positive case. Thus, approx. 20% of the Hp-negative non-Hp-eradicated gastric disease patients treated at 17 hospitals in Japan were infected with NHPH.

Sections du résumé

BACKGROUND BACKGROUND
The clinical significance of non-Helicobacter pylori Helicobacter (NHPH) is still unknown. There are many reports of NHPH-infected patients suffering from gastric diseases. Here, we investigated the polymerase chain reaction (PCR) positivity of NHPH infection in gastric disease patients who were negative for H. pylori (Hp) by the rapid urease test and by pathological observation.
MATERIALS AND METHODS METHODS
We collected the 296 endoscopically obtained gastric mucosal samples of Hp-negative gastric disease patients diagnosed based on a rapid urease test and pathology from 17 hospitals in Japan from September 2013 to June 2019, and we analyzed the existence of Hp and NHPH by PCR. The samples were also treated by indirect immunohistochemistry using an anti-Helicobacter suis VacA paralog antibody and were observed by confocal laser microscopy.
RESULTS RESULTS
Among the 236 non-Hp-eradicated cases, 49 cases (20.8%) were positive for NHPH. Among them, 20 cases were positive for Helicobacter suis, 7 cases were positive for Helicobacter heilmannii sensu stricto/ Helicobacter ailurogastricus (Hhss/Ha), and the other 22 cases could not be identified. The regional differences in the infection rates were significant. Forty percent of the nodular gastritis cases, 24% of the MALT lymphoma, 17% of the chronic gastritis cases, and 33% of the gastroduodenal ulcer cases were NHPH positive. Forty-five patients had been treated with one of the four types of combinations of a proton pump inhibitor and two antibiotics, and in all of these cases, the NHPH diagnosed by PCR was successfully eradicated. Immunohistochemistry using the Helicobacter suis-specific HsvA antibody coincided well with the PCR results. Among the 29 post-Hp eradication cases, three were NHPH positive, including one Hhss/Ha-positive case. Thus, approx. 20% of the Hp-negative non-Hp-eradicated gastric disease patients treated at 17 hospitals in Japan were infected with NHPH.

Identifiants

pubmed: 32790220
doi: 10.1111/hel.12700
doi:

Substances chimiques

Anti-Bacterial Agents 0
Proton Pump Inhibitors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12700

Subventions

Organisme : Japanese Society of Helicobacter Research
Organisme : JSPS KAKENHI
ID : 22590690
Organisme : JSPS KAKENHI
ID : 23790155
Organisme : JSPS KAKENHI
ID : 2159049

Informations de copyright

© 2020 John Wiley & Sons Ltd.

Références

Heilmann KL, Nowottny U. Histologischer Nachweis von CLO (Campylobacter Like Organisms) in Magenbiopsien. Dtsch med Wschr. 1987;112:861.
McNulty CA, Dent JC, Curry A, et al. New spiral bacterium in gastric mucosa. J Clin Pathol. 1989;42:585-591.
Wegmann W, Aschwanden M, Schaub N, et al. Gastritis associated with Gastrospirillum hominis-A zoonosis? Schweizerische Medizinische Wochenschrift. 1991;121:245-254.
Goji S, Tamura Y, Sasaki M, et al. Helicobacter suis-infected nodular gastritis and a review of diagnostic sensitivity for Helicobacter heilmannii-like organisms. Case Rep Gastroenterol. 2015;9:179-187.
Shiratori S, Mabe K, Yoshii S, et al. Two cases of chronic gastritis with non-Helicobacter pylori helicobacter infection. Intern Med. 2016;55:1865-1869.
Nakagawa S, Shimoyama T, Nakamura M, et al. The resolution of Helicobacter suis-associated gastric lesions after eradication therapy. Intern Med. 2018;57:203-207.
Heilmann KL, Brochard F. Gastritis due to spiral shaped bacteria other than Helicobacter pylori: Clinical, histological, and ultrastructural findings. Gut. 1991;32:137-140.
Kubonova K, Trupi J, Jancula L, et al. Presence of spiral bacteria (“Gastrospirillum hominis”) in the gastric mucosa. Eur J Clin Microbiol Infect Dis. 1991;10:459-460.
Yang H, Goliger JA, Song M, et al. High prevalence of Helicobacter heilmannii infection in China. Dig Dis Sci. 1998;43:1493.
Liu J, He L, Haesebrouck F, et al. Prevalence of Coinfection with Gastric Non-Helicobacter pylori Helicobacter (NHPH) species in Helicobacter pylori-infected patients suffering from gastric disease in Beijing, China. Helicobacter. 2015;20:284-290.
Ali B, Chloë DW, Mehmet A, et al. Presence of gastric Helicobacter species in children suffering from gastric disorders in Southern Turkey. Helicobacter. 2018;23(5):e12511.
Zhang Y, Yamada N, Wen M, et al. Gastrospirillum hominis and Helicobacter pylori infection in Thai individuals-Comparison of histopathological changes of gastric mucosa. Pathol Int. 1998;48:507-511.
Nakamura M, Murayama SY, Serizawa H, et al. “Candidatus Helicobacter heilmannii” from a cynomolgus monkey induces gastric mucosa-associated lymphoid tissue lymphomas in C57BL/6 mice. Infect Immun. 2007;75:1214-1222.
Matsui H, Takahashi T, Murayama SY, et al. Draft genome sequence of Helicobacter suis strain SNTW101, isolated from a Japanese patient with nodular gastritis. Genome Announc. 2016;4: e00934-e1916.
Chisholm SA, Owen RJ, Teare EL, Saverymuttu S. PCR-based diagnosis of Helicobacter pylori infection and real-time determination of clarithromycin resistance directly from human gastric biopsy samples. J Clin Microbiol. 2001;39:1217-1220.
Chisholm SA, Owen RJ. Development and application of a novel screening PCR assay for direct detection of 'Helicobacter heilmannii'-like organisms in human gastric biopsies in Southeast England. Diagn Microbiol Infect Dis. 2003;46:1-7.
Joosten M, Linden S, Rossi M, et al. Divergence between the highly virulent zoonotic pathogen Helicobacter heilmannii and its closest relative, the low-virulence “Helicobacter ailurogastricus” sp. nov. Infect Immun. 2015;84:293-306.
O’Rourke JL, Solnick JV, Neilan BA, et al. Description of “Candidatus Helicobacter heilmannii” based on DNA sequence analysis of 16S rRNA and urease genes. Int J Syst Evol Microbiol. 2004;54:2203-2211.
Zamboni L, Cesare DM. Buffered picric acid formaldehyde: a new rapid fixative for electron microscopy. J Cell Biol. 1967;35:148.
Matsui H, Rimbara E, Suzuki M, et al. Development of the rapid diagnostic methods of Helicobacter suis infection. Jpn J Helicobacter Res. 2020;21:121-127. (in Japanese with English abstract).
The Kitasato Institute, et al. Method for diagnosis of Helicobacter suis infection (not yet published). PCT/JP2019/020248.
Øverby A, Murayama SY, Michimae H, et al. Prevalence of gastric non-Helicobacter pylori-Helicobacters in Japanese patients with gastric disease. Digestion. 2017;95:61-66.
Archimandritis A, Apostolopoulos P, Sougioultzis S, et al. The CLO test is unreliable in diagnosing H pylori infection in post-surgical stomach; is there any role of H pylori in peptic ulcer recurrence? Eur J Gastroenterol Hepatol. 2000;12:93-96.
Dechant FX, De Selgrad M, Weber F, et al. Accuracy of different chant R, Kandulski A, rapid urease tests in comparison with histopathology in patients with endoscopic signs of gastritis. Digestion. 2019;28:1-7.
Fawcett PT, Gibney KM, Vinette KM Helicobacter pylori can be induced to assume the morphology of Helicobacter heilmannii. J Clin Microbiol. 1999;37:1045-1048.
Tahara T, Horiguchi N, Yamada H, et al. Comparative study of magnifying narrow-band imaging and conventional white light endoscopy in the diagnosis of Helicobacter pylori status after eradication therapy. Medicine. 2019;98:17697.
Flahou B, Rossi M, Bakker J, et al. Evidence for a primate origin of zoonotic Helicobacter suis colonizing domesticated pigs. ISME J. 2018;12:77-86.
Gorodetskiy VR, Probatova NA, Radenska-Lopovok SG, et al. Clonal relationship of marginal zone lymphoma and diffuse large B-cell lymphoma in Sjögren’s syndrome patients: case series study and review of the literature. Rheumatol Int. 2019;40:499-506. https://doi.org/10.1007/s00296-019-04470-x

Auteurs

Masahiko Nakamura (M)

School of Pharmacy, Kitasato University, Tokyo, Japan.

Anders Øverby (A)

Center of Education in Kongsvinger, Kongsvinger, Norway.

Hirofumi Michimae (H)

Department of Clinical Medicine (Biostatistics), School of Pharmacy, Kitasato University, Tokyo, Japan.

Hidenori Matsui (H)

Kitasato Institute for Life Sciences, Kitasato University, Tokyo, Japan.

Shinichi Takahashi (S)

School of Medicine, Kyorin University, Mitaka, Japan.

Katsuhiro Mabe (K)

Department of Gastroenterology, National Hospital Organization Hakodate National Hospital, Hakodate, Japan.

Tadashi Shimoyama (T)

Aomori General Health Examination Center, Aomori, Japan.

Makoto Sasaki (M)

Department of Gastroenterology, Aichi Medical University, Nagakute, Japan.

Shuici Terao (S)

Kakogawa Central City Hospital, Kakogawa, Japan.

Tomoari Kamada (T)

Department of Health Care Medicine, Kawasaki Medical School, Kurashiki, Japan.

Akinori Yanaka (A)

University of Tsukuba Hitachi Medical Education and Research Center, University of Tsukuda, Hitachi, Japan.

Junichi Iwamoto (J)

Department of Gastroenterology, Tokyo Medical University Ibaraki Medical Center, Amicho, Japan.

Satoshi Tanabe (S)

Department of Advanced Medicine Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine, Sagamihara, Japan.

Akira Tari (A)

Sixth Department of Internal Medicine, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan.

Shinji Nasu (S)

Department of Gastroenterology, Ikeikai Inobe Hospital, Oita, Japan.

Hidekazu Suzuki (H)

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan.

Somay Yamagata Murayama (S)

Laboratory of Medical Microbiology, School of Pharmacy, Nihon University, Funabashi, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH